Eminent scientists headline distinguished lecture seriesAs part of the four-day program of the historic first joint meeting of the American Association for Dental Research (AADR) and the American Dental Education Association (ADEA), convening March 8-11 at the Walt Disney World Swan and Dolphin Hotels, three eminent scientists will speak in the Distinguished Lecture Series.
On Thursday morning, March 9, David Wong of the University of California, Los Angeles will present "Salivary Diagnostics: Powered by Nanotechnologies, Proteomics, and Genomics". Wong will explain the transformation taking place with the increasing awareness, scientific research, and clinical utility of saliva as a diagnostic fluid. Much of this is due to the timely investment by the National Institute of Dental and Craniofacial Research (Bethesda, MD) to develop technologies and diagnostic targets for salivary diagnostics. Nanotechnology-based saliva biosensors that are point-of-care, automated, and self-contained, and which can be used as clinical chair-side devices, are currently being developed. In addition, diagnostic targets in saliva are concurrently being deciphered based on the salivary proteome. The convergence of diagnostic technologies and the salivary proteome will present clinical platforms and diagnostic targets that will have enormous translational and clinical applications and utility.
On Friday morning, March 10, Roderic Pettigrew (National Institute of Biomedical Imaging and Bioengineering, Bethesda, MD) will speak on "Horizons in Biomedical Engineering." Pettigrew, who holds both PhD and MD degrees, will discuss the significant changes in the landscape of biomedical research that have begun in this decade, consequent to the merger of technology and biomedicine. At the intersection of these scientific fields is the promise of new fundamental discoveries and significant progress in the understanding and management of disease. In the bioengineering arena, technological progress in biosensors, biomaterials and tissue engineering, drug and gene delivery systems and devices, medical devices and implant sciences, and micro- and nanotechnology is providing quantitative tools for new insights and therapeutic approaches to disease. This promises improved health care through the development and application of emerging technologies at the interface of the life and quantitative sciences.
On Saturday morning, March 11, New York University's David Grier will address the topic of "Transforming Mesoscopic (Bio)materials with Holographic Optical Traps". Optical trapping is an increasingly important technique for controlling and probing matter at length scales ranging from nanometers to millimeters. This presents exciting new opportunities for fundamental research and substantial real-world commercial applications.
All three programs begin at 8 a.m. The AADR and the ADEA are headquartered in Alexandria, VA, and Washington, DC, respectively, and together represent thousands of research scientists and academicians across the country.
Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.